col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


261 Results       Page 1

 [1] 
eLife Sciences Publications, Ltd.: eLife
  original article Date Title Authors   All Authors
1 [GO] 2024―Aug―28 Recent evolutionary origin and localized diversity hotspots of mammalian coronaviruses Renan Maestri, Benoît Perez-Lamarque, Anna Zhukova, Hélène Morlon
2 [GO] 2024―Jul―16 Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial Joanna C Porter, Jamie Inshaw, Vincente Joel Solis, Emma Denneny, Rebecca Evans, Mia I Temkin, et al. (+19)
3 [GO] 2024―Jul―16 Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID-19: Evidence from a large population-based cohort study Ruijie Zeng, Yuying Ma, Lijun Zhang, Dongling Luo, Rui Jiang, Huihuan Wu, et al. (+7)
4 [GO] 2024―Jun―28 Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2 Ai Nguyen, Huaying Zhao, Dulguun Myagmarsuren, Sanjana Srinivasan, Di Wu, Jiji Chen, et al. (+2)
5 [GO] 2024―Jun―25 Hybrid immunity from SARS-CoV-2 infection and vaccination in Canadian adults: cohort study Patrick E Brown, Sze Hang Fu, Leslie Newcombe, Xuyang Tang, Nico Nagelkerke, H Chaim Birnboim, et al. (+15)
6 [GO] 2024―Jun―12 Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern Callum M Ives, Linh Nguyen, Carl A Fogarty, Aoife M Harbison, Yves Durocher, John Klassen, Elisa Fadda
7 [GO] 2024―May―30 Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease Kejia Zhang, Patrick Eldin, Jessica H Ciesla, Laurence Briant, Jenna M Lentini, Jillian Ramos, et al. (+3)
8 [GO] 2024―May―08 Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies Xiuyuan Lu, Hiroki Hayashi, Eri Ishikawa, Yukiko Takeuchi, Julian Vincent Tabora Dychiao, Hironori Nakagami, Sho Yamasaki
9 [GO] 2024―May―07 Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus Natalia E Ketaren, Fred D Mast, Peter C Fridy, Jean Paul Olivier, Tanmoy Sanyal, Andrej Sali, et al. (+3)
10 [GO] 2024―May―07 Some mechanistic underpinnings of molecular adaptations of SARS-COV-2 spike protein by integrating candidate adaptive polymorphisms with protein dynamics Nicholas James Ose, Paul Campitelli, Tushar Modi, I Can Kazan, Sudhir Kumar, Sefika Banu Ozkan
11 [GO] 2024―Apr―24 Altered transcriptomic immune responses of maintenance hemodialysis patients to the COVID-19 mRNA vaccine Yi-Shin Chang, Kai Huang, Jessica M Lee, Christen L Vagts, Christian Ascoli, Md-Ruhul Amin, et al. (+19)
12 [GO] 2024―Apr―16 A retrospective cohort study of Paxlovid efficacy depending on treatment time in hospitalized COVID-19 patients Zhanwei Du, Lin Wang, Yuan Bai, Yunhu Liu, Eric HY Lau, Alison P Galvani, et al. (+3)
13 [GO] 2024―Apr―04 Associations of proton pump inhibitors with susceptibility to influenza, pneumonia, and COVID-19: Evidence from a large population-based cohort study Ruijie Zeng, Yuying Ma, Lijun Zhang, Dongling Luo, Rui Jiang, Huihuan Wu, et al. (+7)
14 [GO] 2024―Mar―27 Role of N343 glycosylation on the SARS-CoV-2 S RBD structure and co-receptor binding across variants of concern Callum M Ives, Linh Nguyen, Carl A Fogarty, Aoife M Harbison, Yves Durocher, John Klassen, Elisa Fadda
15 [GO] 2024―Mar―20 Murine alveolar macrophages rapidly accumulate intranasally administered SARS-CoV-2 Spike protein leading to neutrophil recruitment and damage Chung Park, Il-Young Hwang, Serena Li-Sue Yan, Sinmanus Vimonpatranon, Danlan Wei, Don Van Ryk, et al. (+4)
16 [GO] 2024―Mar―07 Exploring factors shaping antibiotic resistance patterns in Streptococcus pneumoniae during the 2020 COVID-19 pandemic Aleksandra Kovacevic, David RM Smith, Eve Rahbé, Sophie Novelli, Paul Henriot, Emmanuelle Varon, et al. (+4)
17 [GO] 2024―Feb―28 Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster Julia R Port, Dylan H Morris, Jade C Riopelle, Claude Kwe Yinda, Victoria A Avanzato, Myndi G Holbrook, et al. (+11)
18 [GO] 2024―Feb―28 Disentangling the relationship between cancer mortality and COVID-19 in the US Chelsea L Hansen, Cécile Viboud, Lone Simonsen
19 [GO] 2024―Feb―28 Recent evolutionary origin and localized diversity hotspots of mammalian coronaviruses Renan Maestri, Benoît Perez-Lamarque, Anna Zhukova, Hélène Morlon
20 [GO] 2024―Feb―28 Effect of an enhanced public health contact tracing intervention on the secondary transmission of SARS-CoV-2 in educational settings: The four-way decomposition analysis Olivera Djuric, Elisabetta Larosa, Mariateresa Cassinadri, Silvia Cilloni, Eufemia Bisaccia, Davide Pepe, et al. (+7)
21 [GO] 2024―Feb―20 Transcriptional regulation of SARS-CoV-2 receptor ACE2 by SP1 Hui Han, Rong-Hua Luo, Xin-Yan Long, Li-Qiong Wang, Qian Zhu, Xin-Yue Tang, et al. (+4)
22 [GO] 2024―Feb―06 Modulation of biophysical properties of nucleocapsid protein in the mutant spectrum of SARS-CoV-2 Ai Nguyen, Huaying Zhao, Dulguun Myagmarsuren, Sanjana Srinivasan, Di Wu, Jiji Chen, et al. (+2)
23 [GO] 2024―Jan―24 Hyperglycemia induced cathepsin L maturation linked to diabetic comorbidities and COVID-19 mortality Qiong He, Miao-Miao Zhao, Ming-Jia Li, Xiao-Ya Li, Jian-Min Jin, Ying-Mei Feng, et al. (+4)
24 [GO] 2023―Dec―21 Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16 Huan Wang, Syed RA Rizvi, Danni Dong, Jiaqi Lou, Qian Wang, Watanyoo Sopipong, et al. (+5)
25 [GO] 2023―Dec―12 Cervical cancer screening improvements with self-sampling during the COVID-19 pandemic Miriam Elfström, Penelope Grace Gray, Joakim Dillner
26 [GO] 2023―Nov―22 Lys417 acts as a molecular switch that regulates the conformation of SARS-CoV-2 spike protein Qibin Geng, Yushun Wan, Fu-Chun Hsueh, Jian Shang, Gang Ye, Fan Bu, et al. (+4)
27 [GO] 2023―Nov―21 Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform Enja Tatjana Kipfer, David Hauser, Martin J Lett, Fabian Otte, Lorena Urda, Yuepeng Zhang, et al. (+4)
28 [GO] 2023―Nov―13 Proteolytic cleavage and inactivation of the TRMT1 tRNA modification enzyme by SARS-CoV-2 main protease Kejia Zhang, Patrick Eldin, Jessica H Ciesla, Laurence Briant, Jenna M Lentini, Jillian Ramos, et al. (+3)
29 [GO] 2023―Nov―09 Nanobody repertoire generated against the spike protein of ancestral SARS-CoV-2 remains efficacious against the rapidly evolving virus Natalia E Ketaren, Fred D Mast, Peter C Fridy, Jean Paul Olivier, Tanmoy Sanyal, Andrej Sali, et al. (+3)
30 [GO] 2023―Nov―06 Some mechanistic underpinnings of molecular adaptations of SARS-COV-2 spike protein by integrating candidate adaptive polymorphisms with protein dynamics Nicholas James Ose, Paul Campitelli, Tushar Modi, I Can Kazan, Sudhir Kumar, Sefika Banu Ozkan
31 [GO] 2023―Oct―17 Clinical characteristics, racial inequities, and outcomes in patients with breast cancer and COVID-19: a COVID-19 and cancer consortium (CCC19) cohort study Gayathri Nagaraj, Shaveta Vinayak, Ali Raza Khaki, Tianyi Sun, Nicole M Kuderer, David M Aboulafia, et al. (+91)
32 [GO] 2023―Oct―13 A modelled analysis of the impact of COVID-19-related disruptions to HPV vaccination Louiza S Velentzis, Megan A Smith, James Killen, Julia ML Brotherton, Rebecca Guy, Karen Canfell
33 [GO] 2023―Oct―13 Single-nuclei characterization of pervasive transcriptional signatures across organs in response to COVID-19 Alejandro A Granados, Simon Bucher, Hanbing Song, Aditi Agrawal, Ann T Chen, Tien Peng, et al. (+4)
34 [GO] 2023―Oct―11 Early acquisition of S-specific Tfh clonotypes after SARS-CoV-2 vaccination is associated with the longevity of anti-S antibodies Xiuyuan Lu, Hiroki Hayashi, Eri Ishikawa, Yukiko Takeuchi, Julian Vincent Tabora Dychiao, Hironori Nakagami, Sho Yamasaki
35 [GO] 2023―Sep―22 The importance of patient-partnered research in addressing long COVID: Takeaways for biomedical research study design from the RECOVER Initiative’s Mechanistic Pathways taskforce C Kim, Benjamin Chen, Sindhu Mohandas, Jalees Rehman, Zaki A Sherif, K Coombs
36 [GO] 2023―Sep―21 Within-host diversity improves phylogenetic and transmission reconstruction of SARS-CoV-2 outbreaks Arturo Torres Ortiz, Michelle Kendall, Nathaniel Storey, James Hatcher, Helen Dunn, Sunando Roy, et al. (+7)
37 [GO] 2023―Sep―12 A rapid review of COVID-19’s global impact on breast cancer screening participation rates and volumes from January to December 2020 Reagan Lee, Wei Xu, Marshall Dozier, Ruth McQuillan, Evropi Theodoratou, Jonine Figueroa
38 [GO] 2023―Sep―04 Examining the perceived impact of the COVID-19 pandemic on cervical cancer screening practices among clinicians practicing in Federally Qualified Health Centers: A mixed methods study Lindsay Fuzzell, Paige Lake, Naomi C Brownstein, Holly B Fontenot, Ashley Whitmer, Alexandra Michel, et al. (+5)
39 [GO] 2023―Sep―01 Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment Lindsay Fuzzell, Naomi C Brownstein, Holly B Fontenot, Paige W Lake, Alexandra Michel, Ashley Whitmer, et al. (+4)
40 [GO] 2023―Aug―29 The natural tannins oligomeric proanthocyanidins and punicalagin are potent inhibitors of infection by SARS-CoV-2 Hsiao-Fan Chen, Wei-Jan Wang, Chung-Yu Chen, Wei-Chao Chang, Po-Ren Hsueh, Shin-Lei Peng, et al. (+6)
41 [GO] 2023―Aug―24 Development and validation of COEWS (COVID-19 Early Warning Score) for hospitalized COVID-19 with laboratory features: a multicontinental retrospective study Riku Klén, Ivan A Huespe, Felipe Aníbal Gregalio, Antonio Lalueza Lalueza Blanco, Miguel Pedrera Jimenez, Noelia Garcia Barrio, et al. (+8)
42 [GO] 2023―Aug―22 Electronic data review, client reminders, and expanded clinic hours for improving cervical cancer screening rates after COVID-19 pandemic shutdowns: a multi-component quality improvement program Sue Ghosh, Jackie Fantes, Karin Leschly, Julio Mazul, Rebecca B Perkins
43 [GO] 2023―Aug―18 A review of HPV and HBV vaccine hesitancy, intention, and uptake in the era of social media and COVID-19 Emily K Vraga, Sonya S Brady, Chloe Gansen, Euna Mehnaz Khan, Sarah L Bennis, Madalyn Nones, et al. (+3)
44 [GO] 2023―Aug―17 Nation-wide mammography screening participation in Denmark during the COVID-19 pandemic: an observational study Tina Bech Olesen, Henry Jensen, Henrik Møller, Jens Winther Jensen, Berit Andersen, Ilse Vejborg, Sisse Helle Njor
45 [GO] 2023―Aug―11 Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform Enja Tatjana Kipfer, David Hauser, Martin J Lett, Fabian Otte, Lorena Urda, Yuepeng Zhang, et al. (+4)
46 [GO] 2023―Aug―10 Healthcare in England was affected by the COVID-19 pandemic across the pancreatic cancer pathway: A cohort study using OpenSAFELY-TPP Agnieszka Lemanska, Colm Andrews, Louis Fisher, Seb Bacon, Adam E Frampton, Amir Mehrkar, et al. (+7)
47 [GO] 2023―Aug―03 Association between Bisphosphonate use and COVID-19 related outcomes Jeffrey Thompson, Yidi Wang, Tobias Dreischulte, Olga Barreiro, Rodrigo J Gonzalez, Pavel Hanč, et al. (+6)
48 [GO] 2023―Jul―31 SARS-CoV-2 uses CD4 to infect T helper lymphocytes Natalia S Brunetti, Gustavo G Davanzo, Diogo de Moraes, Allan JR Ferrari, Gabriela F Souza, Stéfanie Primon Muraro, et al. (+70)
49 [GO] 2023―Jul―27 Comparing the evolutionary dynamics of predominant SARS-CoV-2 virus lineages co-circulating in Mexico Hugo G Castelán-Sánchez, Luis Delaye, Rhys PD Inward, Simon Dellicour, Bernardo Gutierrez, Natalia Martinez de la Vina, et al. (+21)
50 [GO] 2023―Jul―27 Eleven key measures for monitoring general practice clinical activity during COVID-19: A retrospective cohort study using 48 million adults’ primary care records in England through OpenSAFELY Louis Fisher, Helen J Curtis, Richard Croker, Milan Wiedemann, Victoria Speed, Christopher Wood, et al. (+42)
51 [GO] 2023―Jul―18 Association of close-range contact patterns with SARS-CoV-2: a household transmission study Jackie Kleynhans, Lorenzo Dall'Amico, Laetitia Gauvin, Michele Tizzoni, Lucia Maloma, Sibongile Walaza, et al. (+7)
52 [GO] 2023―Jul―07 Recapitulation of pathophysiological features of AD in SARS-CoV-2-infected subjects Elizabeth Griggs, Kyle Trageser, Sean Naughton, Eun-Jeong Yang, Brian Mathew, Grace Van Hyfte, et al. (+6)
53 [GO] 2023―Jul―06 Meta-research: The effect of the COVID-19 pandemic on the gender gap in research productivity within academia Kiran GL Lee, Adele Mennerat, Dieter Lukas, Hannah L Dugdale, Antica Culina
54 [GO] 2023―Jun―28 Pan-Canadian survey on the impact of the COVID-19 pandemic on cervical cancer screening and management: cross-sectional survey of healthcare professionals Mariam El-Zein, Rami Ali, Eliya Farah, Sarah Botting-Provost, Eduardo L Franco
55 [GO] 2023―Jun―27 The Impact of COVID-19 on cancer screening and treatment in older adults: the multiethnic cohort study Victoria P Mak, Kami White, Lynne R Wilkens, Iona Cheng, Christopher A Haiman, Loic Le Marchand
56 [GO] 2023―Jun―23 Emerging variants of SARS-CoV-2 NSP10 highlight strong functional conservation of its binding to two non-structural proteins, NSP14 and NSP16 Huan Wang, Syed RA Rizvi, Danni Dong, Jiaqi Lou, Qian Wang, Watanyoo Sopipong, et al. (+5)
57 [GO] 2023―Jun―14 Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial Joanna C Porter, Jamie Inshaw, Vincente Joel Solis, Emma Denneny, Rebecca Evans, Mia I Temkin, et al. (+19)
58 [GO] 2023―Jun―13 Prolonged T-cell activation and long COVID symptoms independently associate with severe COVID-19 at 3 months Marianna Santopaolo, Michaela Gregorova, Fergus Hamilton, David Arnold, Anna Long, Aurora Lacey, et al. (+19)
59 [GO] 2023―Jun―06 Murine alveolar macrophages rapidly accumulate intranasally administered SARS-CoV-2 Spike protein leading to neutrophil recruitment and damage Chung Park, Il-Young Hwang, Serena Li-Sue Yan, Sinmanus Vimonpatranon, Danlan Wei, Don Van Ryk, et al. (+4)
60 [GO] 2023―May―30 Host and viral determinants of airborne transmission of SARS-CoV-2 in the Syrian hamster Julia R Port, Dylan H Morris, Jade C Riopelle, Claude Kwe Yinda, Victoria A Avanzato, Myndi G Holbrook, et al. (+11)
61 [GO] 2023―May―26 Perceived barriers to cervical cancer screening and motivators for at-home human papillomavirus self-sampling during the COVID-19 pandemic: Results from a telephone survey Susan L Parker, Ashish A Deshmukh, Baojiang Chen, David R Lairson, Maria Daheri, Sally W Vernon, Jane R Montealegre
62 [GO] 2023―May―26 Immune mechanisms underlying COVID-19 pathology and post-acute sequelae of SARS-CoV-2 infection (PASC) Sindhu Mohandas, Prasanna Jagannathan, Timothy J Henrich, Zaki A Sherif, Christian Bime, Erin Quinlan, et al. (+3)
63 [GO] 2023―May―16 Quantification of impact of COVID-19 pandemic on cancer screening programmes - a case study from Argentina, Bangladesh, Colombia, Morocco, Sri Lanka, and Thailand Eric Lucas, Raul Murillo, Silvina Arrossi, Martin Bárcena, Youssef Chami, Ashrafun Nessa, et al. (+5)
64 [GO] 2023―May―04 Viral persistence, reactivation, and mechanisms of long COVID Benjamin Chen, Boris Julg, Sindhu Mohandas, Steven B Bradfute
65 [GO] 2023―May―02 Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic Pedro Nascimento de Lima, Rosita van den Puttelaar, Anne I Hahn, Matthias Harlass, Nicholson Collier, Jonathan Ozik, et al. (+3)
66 [GO] 2023―Apr―26 Phylodynamics of SARS-CoV-2 in France, Europe and the world in 2020 Romain Coppée, François Blanquart, Aude Jary, Valentin Leducq, Valentine Marie Ferré, Anna Maria Franco Yusti, et al. (+9)
67 [GO] 2023―Apr―21 Predictive performance of multi-model ensemble forecasts of COVID-19 across European nations Katharine Sherratt, Hugo Gruson, Rok Grah, Helen Johnson, Rene Niehus, Bastian Prasse, et al. (+123)
68 [GO] 2023―Apr―18 Point of View: COVID-19 as a catalyst for reimagining cervical cancer prevention Rebecca Luckett, Sarah Feldman, Yin Ling Woo, Anna-Barbara Moscicki, Anna R Giuliano, Silvia de Sanjose, et al. (+9)
69 [GO] 2023―Apr―06 A modelled evaluation of the impact of COVID-19 on breast, bowel, and cervical cancer screening programmes in Australia Carolyn Nickson, Megan A Smith, Eleonora Feletto, Louiza S Velentzis, Kate Broun, Sabine Deij, et al. (+10)
70 [GO] 2023―Apr―04 An umbrella review of systematic reviews on the impact of the COVID-19 pandemic on cancer prevention and management, and patient needs Taulant Muka, Joshua JX Li, Sahar J Farahani, John PA Ioannidis
71 [GO] 2023―Apr―04 Zooanthroponotic transmission of SARS-CoV-2 and host-specific viral mutations revealed by genome-wide phylogenetic analysis Sana Naderi, Peter E Chen, Carmen Lia Murall, Raphael Poujol, Susanne Kraemer, Bradley S Pickering, et al. (+2)
72 [GO] 2023―Mar―28 Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial Astha Thakkar, Kith Pradhan, Benjamin Duva, Juan Manuel Carreno, Srabani Sahu, Victor Thiruthuvanathan, et al. (+17)
73 [GO] 2023―Mar―22 Pathogenic mechanisms of post-acute sequelae of SARS-CoV-2 infection (PASC) Zaki A Sherif, Christian R Gomez, Thomas J Connors, Timothy J Henrich, William Brian Reeves
74 [GO] 2023―Mar―21 Identification of a conserved S2 epitope present on spike proteins from all highly pathogenic coronaviruses Rui P Silva, Yimin Huang, Annalee W Nguyen, Ching-Lin Hsieh, Oladimeji S Olaluwoye, Tamer S Kaoud, et al. (+20)
75 [GO] 2023―Mar―21 Impact of COVID-19 pandemic on breast and cervical cancer screening in Denmark: A register-based study Mette Hartmann Nonboe, George Napolitano, Jeppe Bennekou Schroll, Ilse Vejborg, Marianne Waldstrøm, Elsebeth Lynge
76 [GO] 2023―Mar―17 Timeline of changes in spike conformational dynamics in emergent SARS-CoV-2 variants reveal progressive stabilization of trimer stalk with altered NTD dynamics Sean M Braet, Theresa SC Buckley, Varun Venkatakrishnan, Kim-Marie A Dam, Pamela J Bjorkman, Ganesh S Anand
77 [GO] 2023―Mar―16 Evaluation of antibody kinetics and durability in health individuals vaccinated with inactivated COVID-19 vaccine (CoronaVac): a cross-sectional and cohort study in Zhejiang, China Hangjie Zhang, Qianhui Hua, Nani Nani Xu, Xinpei Zhang, Bo Chen, Xijun Ma, et al. (+11)
78 [GO] 2023―Feb―23 Reducing societal impacts of SARS-CoV-2 interventions through subnational implementation Mark M Dekker, Luc E Coffeng, Frank P Pijpers, Debabrata Panja, Sake J de Vlas
79 [GO] 2023―Feb―23 The effect of variation of individual infectiousness on SARS-CoV-2 transmission in households Tim K Tsang, Xiaotong Huang, Can Wang, Sijie Chen, Bingyi Yang, Simon Cauchemez, Benjamin John Cowling
80 [GO] 2023―Feb―22 Direct and indirect mortality impacts of the COVID-19 pandemic in the United States, March 1, 2020 to January 1, 2022 Wha-Eum Lee, Sang Woo Park, Daniel M Weinberger, Donald Olson, Lone Simonsen, Bryan T Grenfell, Cécile Viboud
81 [GO] 2023―Feb―21 Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV) William HK Schilling, Podjanee Jittamala, James A Watson, Maneerat Ekkapongpisit, Tanaya Siripoon, Thundon Ngamprasertchai, et al. (+31)
82 [GO] 2023―Feb―13 The landscape of antibody binding affinity in SARS-CoV-2 Omicron BA.1 evolution Alief Moulana, Thomas Dupic, Angela M Phillips, Jeffrey Chang, Anne A Roffler, Allison J Greaney, et al. (+3)
83 [GO] 2023―Feb―10 Regulatory dissection of the severe COVID-19 risk locus introgressed by Neanderthals Evelyn Jagoda, Davide Marnetto, Gayani Senevirathne, Victoria Gonzalez, Kaushal Baid, Francesco Montinaro, et al. (+7)
84 [GO] 2023―Feb―07 Long COVID in cancer patients: preponderance of symptoms in majority of patients over long time period Hiba Dagher, Anne-Marie Chaftari, Ishwaria M Subbiah, Alexandre E Malek, Ying Jiang, Peter Lamie, et al. (+14)
85 [GO] 2023―Feb―03 The impact of the COVID-19 pandemic on Italian population-based cancer screening activities and test coverage: Results from national cross-sectional repeated surveys in 2020 Paolo Giorgi Rossi, Giuliano Carrozzi, Patrizia Falini, Letizia Sampaolo, Giuseppe Gorini, Manuel Zorzi, et al. (+7)
86 [GO] 2023―Feb―02 Coordinated evolution at amino acid sites of SARS-CoV-2 spike Alexey Dmitrievich Neverov, Gennady Fedonin, Anfisa Popova, Daria Bykova, Georgii Bazykin
87 [GO] 2023―Jan―31 The impact of lag time to cancer diagnosis and treatment on clinical outcomes prior to the COVID-19 pandemic: A scoping review of systematic reviews and meta-analyses Parker Tope, Eliya Farah, Rami Ali, Mariam El-Zein, Wilson H Miller, Eduardo L Franco
88 [GO] 2023―Jan―30 International multicenter study comparing COVID-19 in patients with cancer to patients without cancer: impact of risk factors and treatment modalities on survivorship Issam I Raad, Ray Hachem, Nigo Masayuki, Tarcila Datoguia, Hiba Dagher, Ying Jiang, et al. (+46)
89 [GO] 2023―Jan―27 Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open label interventional study Avner Ehrlich, Konstantinos Ioannidis, Makram Nasar, Ismaeel Abu Alkian, Yuval Daskal, Nofar Atari, et al. (+18)
90 [GO] 2023―Jan―25 Nation-wide participation in FIT-based colorectal cancer screening in Denmark during the COVID-19 pandemic: An observational study Tina Bech Olesen, Henry Jensen, Henrik Møller, Jens Winther Jensen, Berit Andersen, Morten Rasmussen
91 [GO] 2023―Jan―25 The SARS-CoV-2 accessory protein Orf3a is not an ion channel, but does interact with trafficking proteins Alexandria N Miller, Patrick R Houlihan, Ella Matamala, Deny Cabezas-Bratesco, Gi Young Lee, Ben Cristofori-Armstrong, et al. (+8)
92 [GO] 2023―Jan―24 Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies Nathan J Cheetham, Milla Kibble, Andrew Wong, Richard J Silverwood, Anika Knuppel, Dylan M Williams, et al. (+31)
93 [GO] 2023―Jan―20 Participation in the nation-wide cervical cancer screening programme in Denmark during the COVID-19 pandemic: an observational study Tina Bech Olesen, Henry Jensen, Henrik Møller, Jens Winther Jensen, Marianne Waldstrøm, Berit Andersen
94 [GO] 2023―Jan―19 Future COVID19 surges prediction based on SARS-CoV-2 mutations surveillance Fares Z Najar, Evan Linde, Chelsea L Murphy, Veniamin A Borin, Haun Wang, Shozeb Haider, Pratul K Agarwal
95 [GO] 2023―Jan―18 A modelling approach to estimate the transmissibility of SARS-CoV-2 during periods of high, low, and zero case incidence Nick Golding, David J Price, Gerard Ryan, Jodie McVernon, James M McCaw, Freya M Shearer
96 [GO] 2022―Dec―21 Procalcitonin for antimicrobial stewardship among cancer patients admitted with COVID-19 Hiba Dagher, Anne-Marie Chaftari, Patricia Mulanovich, Ying Jiang, Ray Hachem, Alexandre E Malek, et al. (+3)
97 [GO] 2022―Dec―20 Cross-talk between red blood cells and plasma influences blood flow and omics phenotypes in severe COVID-19 Steffen M Recktenwald, Greta Simionato, Marcelle GM Lopes, Fabia Gamboni, Monika Dzieciatkowska, Patrick Meybohm, et al. (+6)
98 [GO] 2022―Nov―21 SARS-CoV-2-specific CD4+ and CD8+ T cell responses can originate from cross-reactive CMV-specific T cells Cilia R Pothast, Romy C Dijkland, Melissa Thaler, Renate S Hagedoorn, Michel GD Kester, Anne K Wouters, et al. (+5)
99 [GO] 2022―Nov―16 Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: a retrospective cohort study James A Hay, Stephen M Kissler, Joseph R Fauver, Christina Mack, Caroline G Tai, Radhika M Samant, et al. (+19)
100 [GO] 2022―Nov―07 Revealing druggable cryptic pockets in the Nsp1 of SARS-CoV-2 and other β-coronaviruses by simulations and crystallography Alberto Borsatto, Obaeda Akkad, Ioannis Galdadas, Shumeng Ma, Shymaa Damfo, Shozeb Haider, et al. (+3)
101 [GO] 2022―Nov―07 Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron variant of concern Fulvia Mazzaferri, Massimo Mirandola, Alessia Savoldi, Pasquale De Nardo, Matteo Morra, Maela Tebon, et al. (+14)
102 [GO] 2022―Oct―25 HIV skews the SARS-CoV-2 B cell response toward an extrafollicular maturation pathway Robert Krause, Jumari Snyman, Hwa Shi-Hsia, Daniel Muema, Farina Karim, Yashica Ganga, et al. (+17)
103 [GO] 2022―Oct―21 COVID-19 cluster size and transmission rates in schools from crowdsourced case reports Paul Tupper, Shraddha Pai, Caroline Colijn
104 [GO] 2022―Oct―20 Structure of SARS-CoV-2 M protein in lipid nanodiscs Kimberly A Dolan, Mandira Dutta, David M Kern, Abhay Kotecha, Gregory A Voth, Stephen G Brohawn
105 [GO] 2022―Oct―19 Targeted genomic sequencing with probe capture for discovery and surveillance of coronaviruses in bats Kevin S Kuchinski, Kara D Loos, Danae M Suchan, Jennifer N Russell, Ashton N Sies, Charles Kumakamba, et al. (+20)
106 [GO] 2022―Oct―17 Genetically predicted high IGF-1 levels showed protective effects on COVID-19 susceptibility and hospitalization: a Mendelian randomisation study with data from 60 studies across 25 countries Xinxuan Li, Yajing Zhou, Shuai Yuan, Xuan Zhou, Lijuan Wang, Jing Sun, et al. (+10)
107 [GO] 2022―Oct―17 Variation in the ACE2 receptor has limited utility for SARS-CoV-2 host prediction Nardus Mollentze, Deborah Keen, Uuriintuya Munkhbayar, Roman Biek, Daniel G Streicker
108 [GO] 2022―Oct―14 Early immune markers of clinical, virological, and immunological outcomes in patients with COVID-19: a multi-omics study Zicheng Hu, Kattria van der Ploeg, Saborni Chakraborty, Prabhu S Arunachalam, Diego AM Mori, Karen B Jacobson, et al. (+21)
109 [GO] 2022―Oct―13 Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial Nicolás MS Gálvez, Gaspar A Pacheco, Bárbara M Schultz, Felipe Melo-González, Jorge A Soto, Luisa F Duarte, et al. (+33)
110 [GO] 2022―Oct―11 A model-based analysis of the health impacts of COVID-19 disruptions to primary cervical screening by time since last screen for current and future disruptions Emily A Burger, Inge MCM de Kok, James F O'Mahony, Matejka Rebolj, Erik EL Jansen, Daniel D de Bondt, et al. (+7)
111 [GO] 2022―Oct―05 An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients Bronner P Gonçalves, Matthew Hall, Waasila Jassat, Valeria Balan, Srinivas Murthy, Christiana Kartsonaki, et al. (+40)
112 [GO] 2022―Oct―04 How should COVID-19 vaccines be distributed between the Global North and South: a discrete choice experiment in six European countries Janina I Steinert, Henrike Sternberg, Giuseppe A Veltri, Tim Büthe
113 [GO] 2022―Sep―22 SARS-CoV-2 antibody dynamics in blood donors and COVID-19 epidemiology in eight Brazilian state capitals: A serial cross-sectional study Carlos A Prete Junior, Lewis Fletcher Buss, Charles Whittaker, Tassila Salomon, Marcio K Oikawa, Rafael HM Pereira, et al. (+39)
114 [GO] 2022―Sep―13 Effectiveness of rapid SARS-CoV-2 genome sequencing in supporting infection control for hospital-onset COVID-19 infection: multicenter, prospective study Oliver Stirrup, James Blackstone, Fiona Mapp, Alyson MacNeil, Monica Panca, Alison Holmes, et al. (+42)
115 [GO] 2022―Sep―06 Correction: Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229e Kathryn E Kistler, Trevor Bedford
116 [GO] 2022―Aug―25 A mosaic-type trimeric RBD-based COVID-19 vaccine candidate induces potent neutralization against Omicron and other SARS-CoV-2 variants Jing Zhang, Zi Bo Han, Yu Liang, Xue Feng Zhang, Yu Qin Jin, Li Fang Du, et al. (+19)
117 [GO] 2022―Aug―08 Estimation and worldwide monitoring of the effective reproductive number of SARS-CoV-2 Jana Sanne Huisman, Jérémie Scire, Daniel C Angst, Jinzhou Li, Richard A Neher, Marloes H Maathuis, et al. (+2)
118 [GO] 2022―Aug―01 The unmitigated profile of COVID-19 infectiousness Ron Sender, Yinon Bar-On, Sang Woo Park, Elad Noor, Jonathan Dushoff, Ron Milo
119 [GO] 2022―Jul―26 Developing evolution-resistant drugs for COVID-19 Daniel M Weinreich
120 [GO] 2022―Jul―26 Surveying the experience of postdocs in the United States before and during the COVID-19 pandemic Andréanne Morin, Britney A Helling, Seetha Krishnan, Laurie E Risner, Nykia D Walker, Nancy B Schwartz
121 [GO] 2022―Jul―25 Unsuppressed HIV infection impairs T cell responses to SARS-CoV-2 infection and abrogates T cell cross-recognition Thandeka Nkosi, Caroline Chasara, Andrea O Papadopoulos, Tiza L Nguni, Farina Karim, Mahomed-Yunus S Moosa, et al. (+5)
122 [GO] 2022―Jul―19 Reconstruction of transmission chains of SARS-CoV-2 amidst multiple outbreaks in a geriatric acute-care hospital: a combined retrospective epidemiological and genomic study Mohamed Abbas, Anne Cori, Samuel Cordey, Florian Laubscher, Tomás Robalo Nunes, Ashleigh Myall, et al. (+9)
123 [GO] 2022―Jul―15 Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273 Niels JM Verstegen, Ruth R Hagen, Jet van den Dijssel, Lisan H Kuijper, Christine Kreher, Thomas Ashhurst, et al. (+23)
124 [GO] 2022―Jul―08 Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection Marie Alexandre, Romain Marlin, Mélanie Prague, Severin Coleon, Nidhal Kahlaoui, Sylvain Cardinaud, et al. (+17)
125 [GO] 2022―Jul―05 Controlling SARS-CoV-2 in schools using repetitive testing strategies Andrea Torneri, Lander Willem, Vittoria Colizza, Cécile Kremer, Christelle Meuris, Gilles Darcis, et al. (+2)
126 [GO] 2022―Jul―04 Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine Lea Krutzke, Reinhild Rösler, Ellen Allmendinger, Tatjana Engler, Sebastian Wiese, Stefan Kochanek
127 [GO] 2022―Jul―04 Investigating the relationship of COVID-19 related stress and media consumption with schizotypy, depression, and anxiety in cross-sectional surveys repeated throughout the pandemic in Germany and the UK Sarah Daimer, Lorenz L Mihatsch, Sharon AS Neufeld, Graham K Murray, Franziska Knolle
128 [GO] 2022―Jun―28 Taking on SARS-CoV-2 Paola Kučan Brlić, Ilija Brizić
129 [GO] 2022―Jun―23 Host chitinase 3-like-1 is a universal therapeutic target for SARS-CoV-2 viral variants in COVID-19 Suchitra Kamle, Bing Ma, Chang Min Lee, Gail Schor, Yang Zhou, Chun Geun Lee, Jack A Elias
130 [GO] 2022―Jun―21 Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination Shaun Truelove, Claire P Smith, Michelle Qin, Luke C Mullany, Rebecca K Borchering, Justin Lessler, et al. (+54)
131 [GO] 2022―Jun―20 Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms Julia M Flynn, Neha Samant, Gily Schneider-Nachum, David T Bakan, Nese Kurt Yilmaz, Celia A Schiffer, et al. (+3)
132 [GO] 2022―Jun―14 Transmission networks of SARS-CoV-2 in Coastal Kenya during the first two waves: a retrospective genomic study Charles N Agoti, Lynette Isabella Ochola-Oyier, Simon Dellicour, Khadija Said Mohammed, Arnold W Lambisia, Zaydah R de Laurent, et al. (+30)
133 [GO] 2022―Jun―10 Impact of the COVID-19 pandemic on breast cancer screening indicators in a Spanish population-based program: a cohort study Guillermo Bosch, Margarita Posso, Javier Louro, Marta Roman, Miquel Porta, Xavier Castells, Francesc Macià
134 [GO] 2022―Jun―06 Efferocytosis of SARS-CoV-2-infected dying cells impairs macrophage anti-inflammatory functions and clearance of apoptotic cells Ana CG Salina, Douglas dos-Santos, Tamara S Rodrigues, Marlon Fortes-Rocha, Edismauro G Freitas-Filho, Daniel L Alzamora-Terrel, et al. (+37)
135 [GO] 2022―May―19 Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants François Blanquart, Nathanaël Hozé, Benjamin John Cowling, Florence Débarre, Simon Cauchemez
136 [GO] 2022―May―19 SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies Ceri Alan Fielding, Pragati Sabberwal, James C Williamson, Edward JD Greenwood, Thomas WM Crozier, Wioleta Zelek, et al. (+15)
137 [GO] 2022―May―17 Development and evaluation of a machine learning-based in-hospital COVID-19 disease outcome predictor (CODOP): A multicontinental retrospective study Riku Klén, Disha Purohit, Ricardo Gómez-Huelgas, José Manuel Casas-Rojo, Juan Miguel Antón-Santos, Jesús Millán Núñez-Cortés, et al. (+22)
138 [GO] 2022―May―09 A LAMP sequencing approach for high-throughput co-detection of SARS-CoV-2 and influenza virus in human saliva Robert Warneford-Thomson, Parisha P Shah, Patrick Lundgren, Jonathan Lerner, Jason Morgan, Antonio Davila, et al. (+6)
139 [GO] 2022―Mar―24 Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2 Mohammad Afsar, Rohan Narayan, Md Noor Akhtar, Deepakash Das, Huma Rahil, Santhosh Kambaiah Nagaraj, et al. (+3)
140 [GO] 2022―Mar―24 Conformational dynamics and allosteric modulation of the SARS-CoV-2 spike Marco A Díaz-Salinas, Qi Li, Monir Ejemel, Leonid Yurkovetskiy, Jeremy Luban, Kuang Shen, et al. (+2)
141 [GO] 2022―Mar―24 The inherent flexibility of receptor binding domains in SARS-CoV-2 spike protein Hisham M Dokainish, Suyong Re, Takaharu Mori, Chigusa Kobayashi, Jaewoon Jung, Yuji Sugita
142 [GO] 2022―Mar―23 Post-acute sequelae of COVID-19: A metabolic perspective Philipp E Scherer, John P Kirwan, Clifford J Rosen
143 [GO] 2022―Mar―16 Coagulation factors directly cleave SARS-CoV-2 spike and enhance viral entry Edward R Kastenhuber, Marisa Mercadante, Benjamin Nilsson-Payant, Jared L Johnson, Javier A Jaimes, Frauke Muecksch, et al. (+7)
144 [GO] 2022―Mar―16 Meta-Research: Individual-level researcher data confirm the widening gender gap in publishing rates during COVID-19 Emil Bargmann Madsen, Mathias Wullum Nielsen, Josefine Bjørnholm, Reshma Jagsi, Jens Peter Andersen
145 [GO] 2022―Mar―16 SARS-CoV-2 Nsp14 mediates the effects of viral infection on the host cell transcriptome Michela Zaffagni, Jenna M Harris, Ines L Patop, Nagarjuna Reddy Pamudurti, Sinead Nguyen, Sebastian Kadener
146 [GO] 2022―Mar―15 Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike Andrew R Crowley, Harini Natarajan, Andrew P Hederman, Carly A Bobak, Joshua A Weiner, Wendy Wieland-Alter, et al. (+11)
147 [GO] 2022―Mar―11 Innate lymphoid cells and COVID-19 severity in SARS-CoV-2 infection Noah J Silverstein, Yetao Wang, Zachary Manickas-Hill, Claudia Carbone, Ann Dauphin, Brittany P Boribong, et al. (+11)
148 [GO] 2022―Feb―28 Ribosome profiling of porcine reproductive and respiratory syndrome virus reveals novel features of viral gene expression Georgia M Cook, Katherine Brown, Pengcheng Shang, Yanhua Li, Lior Soday, Adam M Dinan, et al. (+5)
149 [GO] 2022―Feb―22 SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern David W Hawman, Kimberly Meade-White, Jacob Archer, Shanna S Leventhal, Drew Wilson, Carl Shaia, et al. (+9)
150 [GO] 2022―Feb―16 Effect of cancer on outcome of COVID-19 patients: a systematic review and meta-analysis of studies of unvaccinated patients Giulia Di Felice, Giovanni Visci, Federica Teglia, Marco Angelini, Paolo Boffetta
151 [GO] 2022―Feb―09 Inference of the SARS-CoV-2 generation time using UK household data William Stephen Hart, Sam Abbott, Akira Endo, Joel Hellewell, Elizabeth Miller, Nick Andrews, et al. (+3)
152 [GO] 2022―Feb―08 Investigating phenotypes of pulmonary COVID-19 recovery: A longitudinal observational prospective multicenter trial Thomas Sonnweber, Piotr Tymoszuk, Sabina Sahanic, Anna Boehm, Alex Pizzini, Anna Luger, et al. (+14)
153 [GO] 2022―Jan―27 Vaccine-induced COVID-19 mimicry syndrome Eric Kowarz, Lea Krutzke, Marius Külp, Patrick Streb, Patrizia Larghero, Jennifer Reis, et al. (+4)
154 [GO] 2022―Jan―24 Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection Meghan E Garrett, Jared G Galloway, Caitlin Wolf, Jennifer K Logue, Nicholas Franko, Helen Y Chu, et al. (+2)
155 [GO] 2022―Jan―20 What triggers inflammation in COVID-19? Tomohiro Sawa, Takaaki Akaike
156 [GO] 2022―Jan―13 ACE2 is the critical in vivo receptor for SARS-CoV-2 in a novel COVID-19 mouse model with TNF- and IFNγ-driven immunopathology Riem Gawish, Philipp Starkl, Lisabeth Pimenov, Anastasiya Hladik, Karin Lakovits, Felicitas Oberndorfer, et al. (+18)
157 [GO] 2022―Jan―11 Golden Syrian hamster as a model to study cardiovascular complications associated with SARS-CoV-2 infection Zaigham Abbas Rizvi, Rajdeep Dalal, Srikanth Sadhu, Akshay Binayke, Jyotsna Dandotiya, Yashwant Kumar, et al. (+11)
158 [GO] 2021―Dec―20 Structure-guided glyco-engineering of ACE2 for improved potency as soluble SARS-CoV-2 decoy receptor Tümay Capraz, Nikolaus Ferdinand Kienzl, Elisabeth Laurent, Jan W Perthold, Esther Föderl-Höbenreich, Clemens Grünwald-Gruber, et al. (+10)
159 [GO] 2021―Dec―10 Add mass spectrometry to the pandemic toolbox Bart Van Puyvelde, Maarten Dhaenens
160 [GO] 2021―Nov―25 Neutrophil-mediated oxidative stress and albumin structural damage predict COVID-19-associated mortality Mohamed A Badawy, Basma A Yasseen, Riem M El-Messiery, Engy A Abdel-Rahman, Aya A Elkhodiry, Azza G Kamel, et al. (+14)
161 [GO] 2021―Nov―25 The alpha/B.1.1.7 SARS-CoV-2 variant exhibits significantly higher affinity for ACE-2 and requires lower inoculation doses to cause disease in K18-hACE2 mice Rafael Bayarri-Olmos, Laust Bruun Johnsen, Manja Idorn, Line S Reinert, Anne Rosbjerg, Søren Vang, et al. (+7)
162 [GO] 2021―Nov―23 Data-driven methodology for discovery and response to pulmonary symptomology in hypertension through statistical learning and data mining: Application to COVID-19 related pharmacovigilance Xuan Xu, Jessica Kawakami, Nuwan Indika Millagaha Gedara, Jim Riviere, Emma Meyer, Gerald J Wyckoff, Majid Jaberi-Douraki
163 [GO] 2021―Oct―25 Effect of SARS-CoV-2 proteins on vascular permeability Rossana Rauti, Meishar Shahoha, Yael Leichtmann-Bardoogo, Rami Nasser, Eyal Paz, Rina Tamir, et al. (+9)
164 [GO] 2021―Oct―18 Early prediction of in-hospital death of COVID-19 patients: a machine-learning model based on age, blood analyses, and chest x-ray score Emirena Garrafa, Marika Vezzoli, Marco Ravanelli, Davide Farina, Andrea Borghesi, Stefano Calza, Roberto Maroldi
165 [GO] 2021―Oct―12 mRNA vaccine-induced T cells respond identically to SARS-CoV-2 variants of concern but differ in longevity and homing properties depending on prior infection status Jason Neidleman, Xiaoyu Luo, Matthew McGregor, Guorui Xie, Victoria Murray, Warner C Greene, et al. (+2)
166 [GO] 2021―Oct―05 HIV status alters disease severity and immune cell responses in beta variant SARS-CoV-2 infection wave Farina Karim, Inbal Gazy, Sandile Cele, Yenzekile Zungu, Robert Krause, Mallory Bernstein, et al. (+18)
167 [GO] 2021―Sep―30 Inhibition of SARS-CoV-2 polymerase by nucleotide analogs from a single-molecule perspective Mona Seifert, Subhas C Bera, Pauline van Nies, Robert N Kirchdoerfer, Ashleigh Shannon, Thi-Tuyet-Nhung Le, et al. (+14)
168 [GO] 2021―Sep―29 mRNA vaccination in people over 80 years of age induces strong humoral immune responses against SARS-CoV-2 with cross neutralisation of P.1 Brazilian variant Helen Parry, Gokhan Tut, Rachel Bruton, Sian Faustini, Christine Stephens, Philip Saunders, et al. (+19)
169 [GO] 2021―Sep―28 Tiled-ClickSeq for targeted sequencing of complete coronavirus genomes with simultaneous capture of RNA recombination and minority variants Elizabeth Jaworski, Rose M Langsjoen, Brooke Mitchell, Barbara Judy, Patrick Newman, Jessica A Plante, et al. (+18)
170 [GO] 2021―Sep―27 Quantifying the relationship between SARS-CoV-2 viral load and infectiousness Aurélien Marc, Marion Kerioui, François Blanquart, Julie Bertrand, Oriol Mitjà, Marc Corbacho-Monné, et al. (+2)
171 [GO] 2021―Aug―31 Sterically confined rearrangements of SARS-CoV-2 Spike protein control cell invasion Esteban Dodero-Rojas, Jose N Onuchic, Paul Charles Whitford
172 [GO] 2021―Aug―26 Effects of common mutations in the SARS-CoV-2 Spike RBD and its ligand the human ACE2 receptor on binding affinity and kinetics Michael I Barton, Stuart A MacGowan, Mikhail A Kutuzov, Omer Dushek, Geoffrey J Barton, P Anton van der Merwe
173 [GO] 2021―Aug―24 Superspreaders drive the largest outbreaks of hospital onset COVID-19 infections Christopher JR Illingworth, William L Hamilton, Ben Warne, Matthew Routledge, Ashley Popay, Chris Jackson, et al. (+34)
174 [GO] 2021―Aug―20 SARS-CoV-2 shedding dynamics across the respiratory tract, sex, and disease severity for adult and pediatric COVID-19 Paul Z Chen, Niklas Bobrovitz, Zahra Premji, Marion Koopmans, David N Fisman, Frank X Gu
175 [GO] 2021―Aug―20 Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia Alex R Schuurman, Tom DY Reijnders, Anno Saris, Ivan Ramirez Moral, Michiel Schinkel, Justin de Brabander, et al. (+6)
176 [GO] 2021―Aug―20 N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2 Fang Tian, Bei Tong, Liang Sun, Shengchao Shi, Bin Zheng, Zibin Wang, et al. (+2)
177 [GO] 2021―Aug―13 Adult stem cell-derived complete lung organoid models emulate lung disease in COVID-19 Courtney Tindle, MacKenzie Fuller, Ayden Fonseca, Sahar Taheri, Stella-Rita Ibeawuchi, Nathan Beutler, et al. (+15)
178 [GO] 2021―Aug―13 Patterns of within-host genetic diversity in SARS-CoV-2 Gerry Tonkin-Hill, Inigo Martincorena, Roberto Amato, Andrew RJ Lawson, Moritz Gerstrung, Ian Johnston, et al. (+33)
179 [GO] 2021―Aug―13 A proteome-wide genetic investigation identifies several SARS-CoV-2-exploited host targets of clinical relevance Mohd Anisul, Jarrod Shilts, Jeremy Schwartzentruber, James Hayhurst, Annalisa Buniello, Elmutaz Shaikho, et al. (+12)
180 [GO] 2021―Aug―12 A comprehensive look at the COVID-19 pandemic death toll Lone Simonsen, Cecile Viboud
181 [GO] 2021―Aug―05 Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy Sierra M Barone, Alberta GA Paul, Lyndsey M Muehling, Joanne A Lannigan, William W Kwok, Ronald B Turner, et al. (+2)
182 [GO] 2021―Aug―03 Within-host evolutionary dynamics of seasonal and pandemic human influenza A viruses in young children Alvin X Han, Zandra C Felix Garza, Matthijs RA Welkers, René M Vigeveno, Nhu Duong Tran, Thi Quynh Mai Le, et al. (+22)
183 [GO] 2021―Jul―29 Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains Nikhil Faulkner, Kevin W Ng, Mary Y Wu, Ruth Harvey, Marios Margaritis, Stavroula Paraskevopoulou, et al. (+23)
184 [GO] 2021―Jul―27 Identification of drugs associated with reduced severity of COVID-19 - a case-control study in a large population Ariel Israel, Alejandro A Schäffer, Assi Cicurel, Kuoyuan Cheng, Sanju Sinha, Eyal Schiff, et al. (+4)
185 [GO] 2021―Jul―27 Revisiting the guidelines for ending isolation for COVID-19 patients Yong Dam Jeong, Keisuke Ejima, Kwang Su Kim, Shoya Iwanami, Ana I Bento, Yasuhisa Fujita, et al. (+7)
186 [GO] 2021―Jul―12 Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time A Sarah Walker, Emma Pritchard, Thomas House, Julie V Robotham, Paul J Birrell, Iain Bell, et al. (+12)
187 [GO] 2021―Jul―06 Mendelian randomization analysis provides causality of smoking on the expression of ACE2, a putative SARS-CoV-2 receptor Hui Liu, Junyi Xin, Sheng Cai, Xia Jiang
188 [GO] 2021―Jun―30 Tracking excess mortality across countries during the COVID-19 pandemic with the World Mortality Dataset Ariel Karlinsky, Dmitry Kobak
189 [GO] 2021―Jun―29 Rapid feedback on hospital onset SARS-CoV-2 infections combining epidemiological and sequencing data Oliver Stirrup, Joseph Hughes, Matthew Parker, David G Partridge, James G Shepherd, James Blackstone, et al. (+10)
190 [GO] 2021―Jun―24 Impact of COVID-19-related disruptions to measles, meningococcal A, and yellow fever vaccination in 10 countries Katy A M Gaythorpe, Kaja Abbas, John Huber, Andromachi Karachaliou, Niket Thakkar, Kim Woodruff, et al. (+8)
191 [GO] 2021―Jun―22 Smartphone Screen Testing, a novel pre-diagnostic method to identify SARS-CoV-2 infectious individuals Rodrigo M Young, Camila J Solis-Cascante, Andres Barriga-Fehrman, Carlos Abogabir, Alvaro R Thadani, Mariana Labarca, et al. (+13)
192 [GO] 2021―Jun―21 Ketogenic diet restrains aging-induced exacerbation of coronavirus infection in mice Seungjin Ryu, Irina Shchukina, Yun-Hee Youm, Hua Qing, Brandon Hilliard, Tamara Dlugos, et al. (+11)
193 [GO] 2021―Jun―09 FnCas9 based CRISPR diagnostic for rapid and accurate detection of major SARS-CoV2 variants on a paper strip Manoj Kumar, Sneha Gulati, Asgar H Ansari, Rhythm Phutela, Sundaram Acharya, Mohd Azhar, et al. (+9)
194 [GO] 2021―Jun―04 Convalescent plasma use in the United States was inversely correlated with COVID-19 mortality Arturo Casadevall, Quigly Dragotakes, Patrick W Johnson, Jonathon W Senefeld, Stephen A Klassen, R Scott Wright, et al. (+3)
195 [GO] 2021―May―27 A high rate of COVID-19 vaccine hesitancy in a large-scale survey on Arabs Eyad A Qunaibi, Mohamed Helmy, Iman Basheti, Iyad Sultan
196 [GO] 2021―May―18 Avoiding culture shock with the SARS-CoV-2 spike protein Benjamin G Hale
197 [GO] 2021―May―18 Modeling the impact of racial and ethnic disparities on COVID-19 epidemic dynamics Kevin C Ma, Tigist F Menkir, Stephen M Kissler, Yonatan H Grad, Marc Lipsitch
198 [GO] 2021―May―04 Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population Heli Julkunen, Anna Cichońska, P Eline Slagboom, Peter Würtz
199 [GO] 2021―Apr―27 Mechanistic theory predicts the effects of temperature and humidity on inactivation of SARS-CoV-2 and other enveloped viruses Dylan H Morris, Kwe Claude Yinda, Amandine Gamble, Fernando W Rossine, Qishen Huang, Trenton Bushmaker, et al. (+7)
200 [GO] 2021―Apr―26 High infectiousness immediately before COVID-19 symptom onset highlights the importance of continued contact tracing William Stephen Hart, Philip K Maini, Robin N Thompson
201 [GO] 2021―Apr―23 SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation David W Sanders, Chanelle C Jumper, Paul J Ackerman, Dan Bracha, Anita Donlic, Hahn Kim, et al. (+13)
202 [GO] 2021―Apr―20 Sensitivity of ID NOW and RT-PCR for detection of SARS-CoV-2 in an ambulatory population Yuan-Po Tu, Jameel Iqbal, Timothy O'Leary
203 [GO] 2021―Apr―20 Insights from a Pan India Sero-Epidemiological survey (Phenome-India Cohort) for SARS-CoV2 Salwa Naushin, Viren Sardana, Rajat Ujjainiya, Nitin Bhatheja, Rintu Kutum, Akash Kumar Bhaskar, et al. (+130)
204 [GO] 2021―Apr―16 Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols Paul Z Chen, Niklas Bobrovitz, Zahra Premji, Marion Koopmans, David N Fisman, Frank X Gu
205 [GO] 2021―Apr―09 Human airway cells prevent SARS-CoV-2 multibasic cleavage site cell culture adaptation Mart M Lamers, Anna Z Mykytyn, Tim I Breugem, Yiquan Wang, Douglas C Wu, Samra Riesebosch, et al. (+5)
206 [GO] 2021―Apr―08 Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection Nick K Jones, Lucy Rivett, Shaun Seaman, Richard J Samworth, Ben Warne, Chris Workman, et al. (+10)
207 [GO] 2021―Mar―30 Early postmortem mapping of SARS-CoV-2 RNA in patients with COVID-19 and the correlation with tissue damage Stefanie Deinhardt-Emmer, Daniel Wittschieber, Juliane Sanft, Sandra Kleemann, Stefan Elschner, Karoline Frieda Haupt, et al. (+11)
208 [GO] 2021―Mar―29 Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriers Qing Yang, Nicholas R Meyerson, Stephen K Clark, Camille L Paige, Will T Fattor, Alison R Gilchrist, et al. (+19)
209 [GO] 2021―Mar―23 Rare variants increase the risk of severe COVID-19 Frank L van de Veerdonk, Mihai G Netea
210 [GO] 2021―Mar―23 Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation Florence WJ Chioh, Siew-Wai Fong, Barnaby E Young, Kan-Xing Wu, Anthony Siau, Shuba Krishnan, et al. (+13)
211 [GO] 2021―Mar―17 Genomic and healthcare dynamics of nosocomial SARS-CoV-2 transmission Jamie M Ellingford, Ryan George, John H McDermott, Shazaad Ahmad, Jonathan J Edgerley, David Gokhale, et al. (+4)
212 [GO] 2021―Mar―11 Longitudinal proteomic profiling of dialysis patients with COVID-19 reveals markers of severity and predictors of death Jack Gisby, Candice L Clarke, Nicholas Medjeral-Thomas, Talat H Malik, Artemis Papadaki, Paige M Mortimer, et al. (+19)
213 [GO] 2021―Mar―08 An open label trial of anakinra to prevent respiratory failure in COVID-19 Evdoxia Kyriazopoulou, Periklis Panagopoulos, Symeon Metallidis, George N Dalekos, Garyphallia Poulakou, Nikolaos Gatselis, et al. (+33)
214 [GO] 2021―Mar―08 SARS-CoV-2 suppresses anticoagulant and fibrinolytic gene expression in the lung Alan E Mast, Alisa S Wolberg, David Gailani, Michael R Garvin, Christiane Alvarez, J Izaak Miller, et al. (+2)
215 [GO] 2021―Mar―05 Estimating SARS-CoV-2 seroprevalence and epidemiological parameters with uncertainty from serological surveys Daniel B Larremore, Bailey K Fosdick, Kate M Bubar, Sam Zhang, Stephen M Kissler, C Jessica E Metcalf, et al. (+2)
216 [GO] 2021―Mar―02 Association of Toll-like receptor 7 variants with life-threatening COVID-19 disease in males: findings from a nested case-control study Chiara Fallerini, Sergio Daga, Stefania Mantovani, Elisa Benetti, Nicola Picchiotti, Daniela Francisci, et al. (+19)
217 [GO] 2021―Mar―02 Genomic epidemiology of COVID-19 in care homes in the East of England William L Hamilton, Gerry Tonkin-Hill, Emily R Smith, Dinesh Aggarwal, Charlotte J Houldcroft, Ben Warne, et al. (+31)
218 [GO] 2021―Feb―23 COVID-19 CG enables SARS-CoV-2 mutation and lineage tracking by locations and dates of interest Albert Tian Chen, Kevin Altschuler, Shing Hei Zhan, Yujia Alina Chan, Benjamin E Deverman
219 [GO] 2021―Feb―23 Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events Ashish Goyal, Daniel B Reeves, E Fabian Cardozo-Ojeda, Joshua T Schiffer, Bryan T Mayer
220 [GO] 2021―Feb―16 Antimicrobial resistance and COVID-19: Intersections and implications Gwenan M Knight, Rebecca E Glover, C Finn McQuaid, Ioana D Olaru, Karin Gallandat, Quentin J Leclerc, et al. (+5)
221 [GO] 2021―Feb―11 The Spike D614G mutation increases SARS-CoV-2 infection of multiple human cell types Zharko Daniloski, Tristan X Jordan, Juliana K Ilmain, Xinyi Guo, Gira Bhabha, Benjamin R tenOever, Neville E Sanjana
222 [GO] 2021―Feb―08 SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets Palur V Raghuvamsi, Nikhil Kumar Tulsian, Firdaus Samsudin, Xinlei Qian, Kiren Purushotorman, Gu Yue, et al. (+6)
223 [GO] 2021―Feb―05 Quantifying the impact of quarantine duration on COVID-19 transmission Peter Ashcroft, Sonja Lehtinen, Daniel C Angst, Nicola Low, Sebastian Bonhoeffer
224 [GO] 2021―Jan―19 Evidence for adaptive evolution in the receptor-binding domain of seasonal coronaviruses OC43 and 229E Kathryn E Kistler, Trevor Bedford
225 [GO] 2021―Jan―14 Cytokine ranking via mutual information algorithm correlates cytokine profiles with presenting disease severity in patients infected with SARS-CoV-2 Kelsey E Huntington, Anna D Louie, Chun Geun Lee, Jack A Elias, Eric A Ross, Wafik S El-Deiry
226 [GO] 2021―Jan―05 Longitudinal high-throughput TCR repertoire profiling reveals the dynamics of T cell memory formation after mild COVID-19 infection Anastasia A Minervina, Ekaterina A Komech, Aleksei Titov, Meriem Bensouda Koraichi, Elisa Rosati, Ilgar Z Mamedov, et al. (+7)
227 [GO] 2021―Jan―04 SARS-CoV-2 entry into human airway organoids is serine protease-mediated and facilitated by the multibasic cleavage site Anna Z Mykytyn, Tim I Breugem, Samra Riesebosch, Debby Schipper, Petra B van den Doel, Robbert J Rottier, et al. (+2)
228 [GO] 2020―Dec―17 Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring AMR bacterial pneumonia Michaela Gregorova, Daniel Morse, Tarcisio Brignoli, Joseph Steventon, Fergus Hamilton, Mahableshwar Albur, et al. (+24)
229 [GO] 2020―Dec―15 Neutralizing SARS-CoV-2 Eric Poeschla
230 [GO] 2020―Nov―26 A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study Joachim Linssen, Anthony Ermens, Marvin Berrevoets, Michela Seghezzi, Giulia Previtali, Simone van der Sar-van der Brugge, et al. (+17)
231 [GO] 2020―Nov―24 COVID-19 research risks ignoring important host genes due to pre-established research patterns Thomas Stoeger, Luís A Nunes Amaral
232 [GO] 2020―Nov―09 ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities Natalia Zamorano Cuervo, Nathalie Grandvaux
233 [GO] 2020―Nov―09 Single cell multiomic profiling of human lung reveals cell type-specific and age-dynamic control of SARS-CoV2 host genes Allen Wang, Joshua Chiou, Olivier B Poirion, Justin Buchanan, Michael J Valdez, Jamie M Verheyden, et al. (+20)
234 [GO] 2020―Oct―28 Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, Justin DaSilva, Daniel Poston, Julio CC Lorenzi, et al. (+18)
235 [GO] 2020―Oct―26 Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration Qi Yang, Thomas A Hughes, Anju Kelkar, Xinheng Yu, Kai Cheng, Sheldon Park, et al. (+3)
236 [GO] 2020―Oct―12 Early prediction of level-of-care requirements in patients with COVID-19 Boran Hao, Shahabeddin Sotudian, Taiyao Wang, Tingting Xu, Yang Hu, Apostolos Gaitanidis, et al. (+3)
237 [GO] 2020―Oct―01 Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic Chase W Nelson, Zachary Ardern, Tony L Goldberg, Chen Meng, Chen-Hao Kuo, Christina Ludwig, et al. (+2)
238 [GO] 2020―Sep―15 Obesity and diabetes as comorbidities for COVID-19: Underlying mechanisms and the role of viral-bacterial interactions Ilja L Kruglikov, Manasi Shah, Philipp E Scherer
239 [GO] 2020―Sep―07 Quantifying antibody kinetics and RNA detection during early-phase SARS-CoV-2 infection by time since symptom onset Benny Borremans, Amandine Gamble, K C Prager, Sarah K Helman, Abby M McClain, Caitlin Cox, et al. (+2)
240 [GO] 2020―Aug―24 The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship Jon C Emery, Timothy W Russell, Yang Liu, Joel Hellewell, Carl AB Pearson, Gwenan M Knight, et al. (+5)
241 [GO] 2020―Aug―21 Differential occupational risks to healthcare workers from SARS-CoV-2 observed during a prospective observational study David W Eyre, Sheila F Lumley, Denise O'Donnell, Mark Campbell, Elizabeth Sims, Elaine Lawson, et al. (+45)
242 [GO] 2020―Aug―20 3d virtual pathohistology of lung tissue from COVID-19 patients based on phase contrast x-ray tomography Marina Eckermann, Jasper Frohn, Marius Reichardt, Markus Osterhoff, Michael Sprung, Fabian Westermeier, et al. (+4)
243 [GO] 2020―Aug―17 Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC) Colin Pawlowski, Tyler Wagner, Arjun Puranik, Karthik Murugadoss, Liam Loscalzo, AJ Venkatakrishnan, et al. (+13)
244 [GO] 2020―Aug―13 Early analysis of the Australian COVID-19 epidemic David J Price, Freya M Shearer, Michael T Meehan, Emma McBryde, Robert Moss, Nick Golding, et al. (+7)
245 [GO] 2020―Jul―30 Neuropathogenesis of SARS-CoV-2 infection Shumayila Khan, James Gomes
246 [GO] 2020―Jul―14 Does the human placenta express the canonical cell entry mediators for SARS-CoV-2? Roger Pique-Regi, Roberto Romero, Adi L Tarca, Francesca Luca, Yi Xu, Adnan Alazizi, et al. (+3)
247 [GO] 2020―Jul―07 Augmented curation of clinical notes from a massive EHR system reveals symptoms of impending COVID-19 diagnosis Tyler Wagner, FNU Shweta, Karthik Murugadoss, Samir Awasthi, AJ Venkatakrishnan, Sairam Bade, et al. (+26)
248 [GO] 2020―Jul―07 A mechanistic model and therapeutic interventions for COVID-19 involving a RAS-mediated bradykinin storm Mike R Garvin, Christiane Alvarez, J Izaak Miller, Erica T Prates, Angelica M Walker, B Kirtley Amos, et al. (+4)
249 [GO] 2020―Jun―23 Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization PJ Klasse, John P Moore
250 [GO] 2020―Jun―22 Evidence for transmission of COVID-19 prior to symptom onset Lauren C Tindale, Jessica E Stockdale, Michelle Coombe, Emma S Garlock, Wing Yin Venus Lau, Manu Saraswat, et al. (+4)
251 [GO] 2020―Jun―19 Effective control of SARS-CoV-2 transmission between healthcare workers during a period of diminished community prevalence of COVID-19 Nick K Jones, Lucy Rivett, Dominic Sparkes, Sally Forrest, Sushmita Sridhar, Jamie Young, et al. (+28)
252 [GO] 2020―Jun―15 Meta-Research: COVID-19 medical papers have fewer women first authors than expected Jens Peter Andersen, Mathias Wullum Nielsen, Nicole L Simone, Resa E Lewiss, Reshma Jagsi
253 [GO] 2020―Jun―08 A Global Immunological Observatory to meet a time of pandemics Michael J Mina, C Jessica E Metcalf, Adrian B McDermott, Daniel C Douek, Jeremy Farrar, Bryan T Grenfell
254 [GO] 2020―May―28 Knowledge synthesis of 100 million biomedical documents augments the deep expression profiling of coronavirus receptors AJ Venkatakrishnan, Arjun Puranik, Akash Anand, David Zemmour, Xiang Yao, Xiaoying Wu, et al. (+12)
255 [GO] 2020―May―26 SARS-CoV-2 strategically mimics proteolytic activation of human ENaC Praveen Anand, Arjun Puranik, Murali Aravamudan, AJ Venkatakrishnan, Venky Soundararajan
256 [GO] 2020―May―11 Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission Lucy Rivett, Sushmita Sridhar, Dominic Sparkes, Matthew Routledge, Nick K Jones, Sally Forrest, et al. (+20)
257 [GO] 2020―Apr―27 Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome Frank L van de Veerdonk, Mihai G Netea, Marcel van Deuren, Jos WM van der Meer, Quirijn de Mast, Roger J Brüggemann, Hans van der Hoeven
258 [GO] 2020―Apr―06 Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients Gian Paolo Rossi, Viola Sanga, Matthias Barton
259 [GO] 2020―Mar―31 SARS-CoV-2 (COVID-19) by the numbers Yinon M Bar-On, Avi Flamholz, Rob Phillips, Ron Milo
260 [GO] 2020―Mar―25 Publishing in the time of COVID-19 Michael B Eisen, Anna Akhmanova, Timothy E Behrens, Detlef Weigel
261 [GO] 2020―Feb―24 Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19 Katelyn Gostic, Ana C R Gomez, Riley O Mummah, Adam J Kucharski, James O Lloyd-Smith
 [1] 

261 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.011 sec